Mesenchymal stem cells as living anti-inflammatory therapy for COVID-19 related acute respiratory distress syndrome

Coronavirus disease 2019 (COVID-19), a pandemic disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV2), is growing at an exponential rate worldwide. Manifestations of this disease are heterogeneous; however, advanced cases often exhibit various acute respiratory distress s...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Feng, Ichim, Thomas E, Pingle, Sandeep, Jones, Lawrence D, Kesari, Santosh, Ashili, Shashaanka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596438/
https://www.ncbi.nlm.nih.gov/pubmed/33178392
http://dx.doi.org/10.4252/wjsc.v12.i10.1067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596438/
https://www.ncbi.nlm.nih.gov/pubmed/33178392
http://dx.doi.org/10.4252/wjsc.v12.i10.1067

Ejemplares similares